Dramatically changed immune‐related molecules as early diagnostic biomarkers of non‐small cell lung cancer
Xiangdong Ye(Wuhan University), Hui Sun(Shanghai Medical College of Fudan University), Yanting Su(Hubei University of Science and Technology), Pengfei Cheng(Ningbo University), Bo Xu(Fuzhou University), Yongsheng Gong(Suzhou Municipal Hospital), Xiangning Fu(Tongji University), Xueqing Wang(Shandong University), Liming Cheng(Tongji Hospital), Ni Zhang(Tongji Hospital), Yanxia Jin(Wuhan University), Jiaqi Song(Nanjing Institute of Geology and Paleontology), Qing Yang(Guangzhou University of Chinese Medicine), Wenhui Yu(Sun Yat-sen University), Chanyuan Guo(Wuhan University)
Cited by 30
Related Papers
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183